View in EDS HTML Full Text PDF Full Text

An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.

Saved in:
Bibliographic Details
Title: An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.
Authors: Walling DP; Collaborative Neuroscience Network, LLC, 12772 Valley View St. Ste 3, Garden Grove, CA, 92845, USA., Shinde SN; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA., Pogoda JM; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA., Kharidia J; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA., Laffont CM; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA. celine.laffont@indivior.com.
Source: Clinical drug investigation [Clin Drug Investig] 2024 Apr; Vol. 44 (4), pp. 251-260. Date of Electronic Publication: 2024 Feb 22.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38388986
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; Collaborative Neuroscience Network, LLC, 12772 Valley View St. Ste 3, Garden Grove, CA, 92845, USA.<br /><searchLink fieldCode="AU" term="%22Shinde+SN%22">Shinde SN</searchLink>; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA.<br /><searchLink fieldCode="AU" term="%22Pogoda+JM%22">Pogoda JM</searchLink>; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA.<br /><searchLink fieldCode="AU" term="%22Kharidia+J%22">Kharidia J</searchLink>; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA.<br /><searchLink fieldCode="AU" term="%22Laffont+CM%22">Laffont CM</searchLink>; Research and Development, Indivior Inc., 10710 Midlothian Turnpike, North Chesterfield, VA, 23235, USA. celine.laffont@indivior.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2024 Apr; Vol. 44 (4), pp. 251-260. <i>Date of Electronic Publication: </i>2024 Feb 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38388986
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-024-01347-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 251
    Titles:
      – TitleFull: An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Walling DP
      – PersonEntity:
          Name:
            NameFull: Shinde SN
      – PersonEntity:
          Name:
            NameFull: Pogoda JM
      – PersonEntity:
          Name:
            NameFull: Kharidia J
      – PersonEntity:
          Name:
            NameFull: Laffont CM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1